
Genomic Analysis of Uveal Melanoma Case with Good Response to Therapy
Personalized OncoGenomics case report provides insight into uveal melanoma and immune checkpoint inhibitor therapy.
Gene expression analysis of pancreatic ductal adenocarcinoma (PDAC) tumours enables clinicians to stratify patients into molecular subgroups and select treatments that are best suited to each type; however, molecular subtyping remains cost-prohibitive and is not yet part of routine cancer care.
As researchers work towards establishing whole genome and transcriptome analysis into clinical practice for cancer care, scientists at the GSC continue developing innovative laboratory methods to improve efficiency and accuracy.